Overview

Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)

Status:
Unknown status

Trial end date:
2015-11-01

Target enrollment:

Participant gender:

Summary

safety and efficacy of different iron chelation therapy in transfusion dependent beta-thalaasemia patients with low serum ferritin and continued regular transfusion regimen.

Phase:

N/A

Details

Lead Sponsor:

Ain Shams University

Treatments:

Deferiprone
Deferoxamine